Kidney Research and Clinical Practice 2018 Mar; 37(1): 98-99  https://doi.org/10.23876/j.krcp.2018.37.1.98
Sustained uremic toxin control improves renal and cardiovascular outcomes in patients with advanced renal dysfunction: post-hoc analysis of the Kremezin Study against renal disease progression in Korea [Volume 36, Issue 1, March 2017, Pages 68–78]
Ran-hui Cha1, Shin Wook Kang2, Cheol Whee Park3, Dae Ryong Cha4, Ki Young Na5,6, Sung Gyun Kim7, Sun Ae Yoon8, Sejoong Kim5,6, Sang Youb Han9, Jung Hwan Park10, Jae Hyun Chang11, Chun Soo Lim6,12, and Yon Su Kim6,13
1Department of Internal Medicine, National Medical Center, Seoul, Korea, 2Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea, 3Department of Internal Medicine, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea, 4Department of Internal Medicine, Korea University Ansan-Hospital, Korea University College of Medicine, Seoul, Korea, 5Department of Internal Medicine, Seoul National University Bundang Hopsital, Seongnam, Korea, 6Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea, 7Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang, Korea, 8Department of Internal Medicine, Uijeongbu St. Mary’s Hospital, The Catholic University of Korea, Uijeongbu, Korea, 9Department of Internal Medicine, Inje University Ilsan-Paik Hospital, Goyang, Korea, 10Department of Internal Medicine, Konkuk University School of Medicine, Seoul, Korea, 11Department of Internal Medicine, Gachon University Gil Medical Center, Gachon University of Medicine and Science, Incheon, Korea, 12Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Korea, 13Kidney Research Institute, Seoul National University, Seoul, Korea
Correspondence to: Yon Su Kim, Department of Internal Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 03080, Korea. E-mail: yonsukim@snu.ac.kr. ORCID: http://orcid.org/0000-0003-3091-2388
Published online: March 31, 2018.
© The Korean Society of Nephrology. All rights reserved.

This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Body

The above article ( https://doi.org/10.23876/j.krcp.2017.36.1.68) contains errors.

The values of y axis in Fig. 3 should be corrected as following page.

The authors would like to apologize for any inconvenience this has caused.

Change of estimated glomerular filtration rate (eGFR) over time

(A) From whole per-protocol participants (Prandomization = 0.18, Prandomization-time = 0.04). (B) From participants without a composite primary outcome (Prandomization = 0.01). (C) From participants with a composite primary outcome (Prandomization = 0.28). (D) From participants with diabetic nephropathy (Prandomization = 0.54, Prandomization-time = 0.049). (E) From participants with non-diabetic nephropathy (Prandomization = 0.21).



e-submission

This Article


Cited By Articles
  • CrossRef (0)
  • PMC (0)
  • SCOPUS (0)

Services
Social Network Service

Archives

Indexed/Covered by